AbCellera Biologics Inc. · NASDAQ:ABCL
AbCellera Biologics Inc. shareholders
As of Sep 30, 2026, 162 institutions reported holding AbCellera Biologics Inc., 40.2% of its shares. Largest: Baker Bros. Advisors LP, Capital Group and Two Sigma. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of AbCellera Biologics Inc. | Change | Filed |
|---|---|---|---|---|
| Baker Bros. Advisors LP | 33M | 10.1% | +1 | Nov 16, 2026 |
| Capital Group | 13.6M | 4.2% | −9,233 | Nov 12, 2026 |
| Two Sigma | 11.7M | 3.6% | +1.26M | Nov 16, 2026 |
| TD | 9.22M | 2.8% | −346K | Oct 16, 2026 |
| Marshall Wace, LLP | 8.96M | 2.7% | +7.06M | Nov 13, 2026 |
| BlackRock | 5.66M | 1.7% | +1.86M | Nov 13, 2026 |
| ArrowMark Colorado Holdings LLC | 4.82M | 1.5% | +718K | Nov 16, 2026 |
| Bank of America | 4.18M | 1.3% | −1.96M | Nov 16, 2026 |
| D. E. Shaw & Co., Inc. | 3.66M | 1.1% | +3.61M | Nov 16, 2026 |
| Alyeska Investment Group, L.P. | 3.06M | 0.94% | +2.54M | Nov 16, 2026 |